Skip to main content

Lanxess plans oxone monopersulfate expansion

Lanxess has announced plans to invest “a lower double-digit million euro sum” in order to expand oxone monopersulfate capacity at its site in Memphis, Tennessee, by 50% by the end of 2022. This comes in response to “continuous strong demand for disinfectants”, the company said.

Lanxess realigns in water treatment

Lanxess has announced that it is focusing its water treatment technologies business on the ion exchange (IX) resins business and will build a new plant. As a result, it is selling its reverse osmosis (RO) membranes business to Suez of France, on undisclosed terms. This should be concluded within 2020.

Subscribe to Lanxess

 

 

 

AMRI banner advert